Future Science Group (FSG) is excited to announce the release of the 10-Year Anniversary Special Focus Issue of Regenerative Medicine entitled “Regenerative medicine: past, present and future”, which reflects on how the field has changed in the past 10 years.
The special issue takes a look at the past decade in regenerative medicine and provides an overview and perspectives on the progress being made in the field as a whole, as well as in a number of more specific areas including cellular therapy, genome editing, pluripotent stem cell research, ligament regenerative engineering, nanotechnology, immunogenicity and regenerative pharmacology. The issue also provides insight into major institutions involved in the field of regenerative medicine, describing their history, current work and plans for the future.
The Special Focus Issue has been guest edited by Robert Lanza (Astellas Institute for Regenerative Medicine, MA, USA), who serves as one of the journal’s Associate Editors. Lanza commented: “The field of regenerative medicine has continued to grow and change rapidly in the past 10 years. We believe that these articles help highlight important advances that have occurred, and that are likely to impact the future success of the field. The publication of this special issue celebrates an exciting milestone for Regenerative Medicine – the tenth year anniversary of the journal. I hope you will join me in congratulating the journal for reaching this major milestone.”
View the special focus issue here, which contains a selection of free and open access content including a Foreword by Robert Lanza, Editorial by Dusko Ilic, as well as a Special Report, Perspective and two Reviews.Call for papers
The journal is currently inviting submissions of original research, review and perspective pieces, as well as shorter pieces such as editorials and organizational profiles. Submissions are being accepted via the journal’s online submission site. Alternatively, authors are invited to direct any article proposals or general queries to the Commissioning Editor, Adam Price-Evans at email@example.com.